GeneLeap is reimagining the future of prescribing drugs, combining methods from genomic sequence analysis and generative AI to revolutionize individualized treatment optimization.
We are passionate about improving lives using innovations built from the latest advances in biomedical and information technologies. We focus first on patients, and their providers, to identify challenges in medicine that new science and technologies can tackle. We value the highest scientific principles, integrity, transparency and compassion–for patients, their physicians, our team and collaborators.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Menlo Park, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.geneleap.com/
- Keywords
- San Diego.
- HQ
- Menlo Park, CA
Geneleap Questions
Geneleap's website is https://www.geneleap.com/
Geneleap's LinkedIn profile is https://www.linkedin.com/company/geneleap
Geneleap has
2 employees.
View email and phone details for 2
employees at Geneleap.
Geneleap's industry is
Biotechnology Research
Geneleap's top competitors are
Tempus Ai,
Epigenic Therapeutics,
Biorex Food Diagnostics,
Glenbio Ltd,
Alcance Genomics Llc,
Exact Sciences,
Leap Ai,
Cv6 Therapeutics, (Ni) Ltd.,
Geneleap Biotech Luye Pharm,
Precision Medicine Advisors.
Geneleap's categories are Biotechnology Research
Geneleap's founding year is 2024
